Association between travel burden and surgical timeliness for women with breast cancer in Georgia
- PMID: 40578069
- PMCID: PMC12355562
- DOI: 10.1016/j.amjsurg.2025.116484
Association between travel burden and surgical timeliness for women with breast cancer in Georgia
Abstract
Introduction: This study evaluates associations between patient distance traveled to surgical care and receipt of timely breast cancer surgery in Georgia.
Methods: This retrospective cohort study included electronic health record data from women diagnosed with stage I-III breast cancer from 2004 to 2020 who received upfront surgery. Race was self-reported. Distance from patient home address to surgical treatment facility was measured as crow-fly distance. Multivariable logistic regression models estimated associations between time to surgery, race, and distance.
Results: Of 18,240 patients (White = 61 % and Black = 39 %) with a median distance to surgery of 11.4 miles (IQR: 5.9, 19.6), Black patients had approximately half the odds of receiving surgery within the recommended 60 days of diagnosis (OR: 0.52, 95 % CI: 0.47-0.56). Distance traveled was not associated with time to surgery.
Conclusion: Understanding mechanisms driving surgical care delays and their effects on breast cancer outcomes is critical to reducing inequities in breast cancer care.
Copyright © 2025 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of competing interest This study was approved by the Georgia State University Institutional Review Board (IRB) and by the hospitals providing data. The IRB waived the need for consent as medical record data were collected retrospectively. This research did not receive any specific grants from funding agencies in the public, commercial, or not-for-profit sectors. Dr. Rademacher receives support from the Agency for Healthcare Research and Quality (T32 HS013852). Dr. Williams receives support from a National Cancer Institute Mentored Research Scientist Development Award (K01CA296932-01). Dr. McElroy received support from a National Institute of Health Grant (T32 CA229102). Dr. Gogineni receives funding from Calithera, Merck, Genentech, SeaGen, Metaclipse, DOD. The authors have no relevant financial or other conflicts of interest related to the conduct of this work. Dr. Williams discloses research funding from Flatiron Health. Dr. Gogineni serves in an advisory role to Pfizer and receives honoraria from AmerisourceBergen.
Figures
Similar articles
-
A latent class assessment of healthcare access factors and disparities in breast cancer care timeliness.PLoS Med. 2024 Dec 2;21(12):e1004500. doi: 10.1371/journal.pmed.1004500. eCollection 2024 Dec. PLoS Med. 2024. PMID: 39621782 Free PMC article.
-
Racial Disparities in Receipt of Guideline-Concordant Care in Older Adults With Early Breast Cancer.JAMA Netw Open. 2024 Oct 1;7(10):e2441056. doi: 10.1001/jamanetworkopen.2024.41056. JAMA Netw Open. 2024. PMID: 39446324 Free PMC article.
-
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2. Cochrane Database Syst Rev. 2022. PMID: 36161421 Free PMC article.
-
Prescription of Controlled Substances: Benefits and Risks.2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 30726003 Free Books & Documents.
-
Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer.Cochrane Database Syst Rev. 2015 Apr 7;(4):CD010260. doi: 10.1002/14651858.CD010260.pub2. Cochrane Database Syst Rev. 2015. Update in: Cochrane Database Syst Rev. 2022 Aug 22;8:CD010260. doi: 10.1002/14651858.CD010260.pub3. PMID: 25847525 Updated.
References
-
- Common Cancer Sites - Cancer Stat Facts. SEER. Accessed December 22, 2024. https://seer.cancer.gov/statfacts/html/common.html
-
- Hoppe EJ, Hussain LR, Grannan KJ, Dunki-Jacobs EM, Lee DY, Wexelman BA. Racial disparities in breast cancer persist despite early detection: analysis of treatment of stage 1 breast cancer and effect of insurance status on disparities. Breast Cancer Res Treat 2019;173(3):597–602. doi: 10.1007/s10549-018-5036-z - DOI - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources